Second relapse of FLT3-ITD-positive acute myeloid leukemia after discontinuation of 3-year post-transplant maintenance therapy with gilteritinib.
Keiji TasakaItaru KatoShunki TakeshitaYu YoshiokaAyuko UsamiYoshinori UchiharaRyo AkazawaTatsuya KamitoriSatoshi SaidaKatsutsugu UmedaHidefumi HiramatsuSouichi AdachiJunko TakitaPublished in: Pediatric blood & cancer (2022)